doi: 10.1016/j.cell.2023.11.009 96 ObandaDNet al
Myth 2: GLP-1 Medications Deliver Instant, Permanent Results GLP-1 medications dont promise instant or permanent weight loss
Reflecting a growing acceptance of obesity as a legitimate medical condition, at least in the United State, a 2024 employer health benefits survey found that 61% of respondents support expanding Medicare (federal health insurance program primarily for individuals aged 65 and older) coverage beyond treatment for T2DM to include GLP-1 therapies for weight management in overweight individuals (Kaiser Family, F, 2024)
Glutathione and Inflammatory Disorders of the lungs
Research, including the STEP 1 extension study with semaglutide, consistently shows that most people experience a return of appetite to pre-treatment levels within weeks of discontinuation
GLP-1 medications like semaglutide and tirzepatide work differently: they slow gastric emptying so you feel full longer and act on appetite regulation in the brain, which many patients describe as quieting constant thoughts about food